Trade Summary

3 months ago, Angel Matthew, serving as CEO and President at Tempest Therapeutics, Inc. (TPST), purchased 231,482 shares at $2.16 per share, for a total transaction value of $500,001.12. Following this transaction, Angel Matthew now holds 231,482 shares of TPST.

The trade was executed on Tuesday, March 24, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 23, 2026 at 4:56 PM ET, 91 days after the trade was made.

Tempest Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.